The Sarcoma JournalFB Support Groups Enable Rapid Access to Large Numbers of Patients With Rare Disease December 13, 2019Sarcoma & GIST
The Sarcoma JournalPexidartinib Receives Category 1 Recommendation from NCCNDecember 13, 2019Sarcoma & GIST
The Sarcoma JournalMetastatic angiosarcoma arising in a patient with long-standing treatment-refractory hemangiomaDecember 13, 2019AngiosarcomaSarcoma & GIST
The Sarcoma JournalBecoming the paradigm for clinical trial enrollmentDecember 13, 2019Sarcoma & GIST
The Sarcoma JournalOvercoming barriers to clinical trial enrollment in patients with bone and soft tissue sarcoma: a paradigm for an increasingly heterogeneous cancer populationDecember 13, 2019Sarcoma & GIST
The Sarcoma JournalConference Coverage: ASCO 2019September 17, 2019Ewing's SarcomaGISTRhabdomyosarcomaSarcoma & GIST
The Sarcoma JournalSignificant clinical response induced by vismodegib in advanced sarcoma: Hedgehog pathway inhibitionSeptember 17, 2019Sarcoma & GIST
Oncology PracticeRozlytrek approved for ROS1-positive metastatic NSCLC, cancers with NTRK gene fusion defectsAugust 15, 2019Lung CancerSarcoma & GIST
Hospital Physician: Hematology/OncologyGastrointestinal Stromal Tumors: Management of Localized Disease August 5, 2019GISTSarcoma & GIST
Hospital Physician: Hematology/OncologyGastrointestinal Stromal Tumors: Management of Advanced DiseaseAugust 5, 2019GISTSarcoma & GIST
Oncology PracticeFDA approves Turalio for symptomatic tenosynovial giant cell tumorAugust 2, 2019Sarcoma & GISTRare Diseases
